Group One Trading’s Acura Pharmaceuticals ACUR Stock Holding History

Group One Trading’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-6,600	Closed	-$17K	–	5338
2015 Q4	$17K	Hold	6,600	–	–	﹤0.01%	4002
2015 Q3	$16K	Buy	6,600 +5,280	+400%	+$18K	﹤0.01%	4143
2015 Q2	$7K	Buy	+1,320	New	+$5.48K	﹤0.01%	4417
2014 Q4	–	Sell	-1,080	Closed	-$4K	–	5609
2014 Q3	$4K	Buy	1,080 +100	+10%	+$469	﹤0.01%	4813
2014 Q2	$5K	Buy	+980	New	+$5.94K	﹤0.01%	4791
2014 Q1	–	Sell	-1,280	Closed	-$11K	–	5855
2013 Q4	$11K	Buy	1,280 +800	+167%	+$6.76K	﹤0.01%	4561
2013 Q3	$5K	Sell	480 -940	-66%	-$8.31K	﹤0.01%	4779
2013 Q2	$13K	Buy	+1,420	New	+$16K	﹤0.01%	4336

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Group One Trading's ACUR Position: Q1 2017 in Review

Group One Trading sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 807 shares — an estimated $1K sold.

Group One Trading first reported a position in ACUR in Q2 2013 and held it in 13 quarters. The position peaked at $10K in Q3 2013. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

Group One Trading reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Group One Trading sold 807 Acura Pharmaceuticals shares in Q1 2017, an estimated $1K.
Group One Trading first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 13 quarters.
Group One Trading's Acura Pharmaceuticals position peaked at $10K in Q3 2013.
3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Group One Trading's 13F filing for Q1 2017, filed 10 May 2017.